+131.0%
UNP vs MRNA
+786.4%
-655.4%
-38.7%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 10y.
| Period | Portfolio | MRNA | Excess | Alpha |
|---|---|---|---|---|
| 1D | -1.1% | -2.2% | +1.0% | -1.1% |
| 7D | -5.0% | -12.7% | +7.7% | -4.8% |
| 30D | -0.2% | -20.7% | +20.5% | +0.1% |
| 3M | -5.0% | +46.3% | -51.3% | -5.8% |
| 6M | +9.2% | +305.2% | -296.1% | +4.7% |
| YTD | +26.1% | +561.2% | -535.2% | +19.0% |
| 1Y | +32.6% | +772.1% | -739.5% | +24.1% |
| 3Y | +38.8% | +147.0% | -108.1% | +32.2% |
| 5Y | +33.3% | -26.1% | +59.3% | +26.9% |
| All | +131.0% | +786.4% | -655.4% | +120.7% |
Cumulative growth
Daily Returns
Daily percentage return beside MRNA.
Daily Out/Under-Performance
Portfolio return minus MRNA return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 10y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
10y analysis · Full analysis span regression · 6 months rolling